CDTTWCDT Equity Inc.
0.0099USD-13.91%Mkt Cap: —P/E: —3d ago
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-39.22M $
Revenue/Share—
Last Price0.0099 USD
Fiscal Year End—
MR Quarter—
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)—
EPS (Forward)—
52W Range
0.006326% of range0.0200
52W High0.0200 USD
52W Low0.0063 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE547.06%
ROA-694.23%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.55M $
CapEx (TTM)2.40M $
FCF Margin—
FCF Yield—
Net Debt435.00K $
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity-0.11
Current Ratio0.13
Quick Ratio0.04
Book Value/Sh163.36 USD
Cash/Share0.9500 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float752.12K
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.49
S&P 52W Chg18.16%
Avg Vol (30d)35.51K
Avg Vol (10d)—
Technical Indicators
RSI (14)47.5
MACD0.0001
MACD Signal0.0003
MACD Hist.-0.0002
BB Upper0.0156 USD
BB Middle0.0117 USD
BB Lower0.0077 USD
BB Width68.38%
ATR (14)0.0034 USD
Vol Ratio (20d)0.02x